Acción SCPH SCPHARMACEUTICALS INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas scPharmaceuticals Inc.

Acciones

SCPH

US8106481059

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 28/06/2024 		Varia. Cinco días. Varia. 1 de enero.
4,35 USD -0,46 % Gráfico intradía de scPharmaceuticals Inc. +7,94 % -30,62 %
14/05 Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024
14/05 ScPharmaceuticals Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
ScPharmaceuticals to Present at the Jefferies Global Healthcare Conference
ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
ScPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
ScPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
ScPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector Injection
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection
ScPharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
ScPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
ScPharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
ScPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences
ScPharmaceuticals Expects Higher Q4 Product Sales
ScPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
ScPharmaceuticals Inc. Provides Revenue Guidance for the Full Year 2023
ScPharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
ScPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
ScPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción SCPH
  4. Noticias scPharmaceuticals Inc.
  5. Otros idiomas